Over the past 12 months, 2 insiders at Corvus Pharmaceuticals, Inc. filed 3 open-market SEC Form 4 transactions on CRVS: 3 purchases worth $334K and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on Jun 11, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 26 | David Scott Moore | BUY | 21.7K | $11.53 | $250K |
| May 18, 26 | Miller Richard A MdPresident and CEO | BUY | 5.0K | $12.05 | $60K |
| Jun 27, 25 | Orbimed Advisors LlcDirector,TenPercentOwner | SELL | 1.18M | $4.16 | $4.9M |
| Jun 27, 25 | Peter A. ThompsonDirector,TenPercentOwner | SELL | 1.18M | $4.16 | $4.9M |
| May 6, 24 | William Benton JonesSee Remarks | BUY | 20.0K | $1.73 | $35K |
| May 6, 24 | Miller Richard A MdPresident and CEO | BUY | 577.6K | $1.73 | $999K |
| May 15, 23 | Linda GraisDirector | BUY | 10.0K | $2.45 | $25K |
| Dec 20, 22 | William Benton JonesSee Remarks | BUY | 20.0K | $0.79 | $16K |
| Dec 14, 22 | Leiv LeaChief Financial Officer | BUY | 4.0K | $0.84 | $3K |
| Dec 14, 22 | Miller Richard A MdPresident and CEO | BUY | 10.0K | $0.78 | $8K |
| Dec 13, 22 | Leiv LeaChief Financial Officer | BUY | 30.0K | $0.74 | $22K |
| Dec 13, 22 | Miller Richard A MdPresident and CEO | BUY | 50.0K | $0.74 | $37K |
| Sep 28, 22 | Miller Richard A MdPresident and CEO | BUY | 25.0K | $0.76 | $19K |
| Sep 20, 22 | Miller Richard A MdPresident and CEO | BUY | 12.3K | $0.82 | $10K |
| Jun 27, 22 | Miller Richard A MdPresident and CEO | BUY | 5.0K | $1.00 | $5K |
| Jun 24, 22 | Miller Richard A MdPresident and CEO | BUY | 5.0K | $1.03 | $5K |
| Jun 6, 22 | Miller Richard A MdPresident and CEO | BUY | 890 | $1.01 | $899 |
| Jun 2, 22 | Miller Richard A MdPresident and CEO | BUY | 4.8K | $0.98 | $5K |
| Mar 31, 22 | Miller Richard A MdPresident and CEO | BUY | 15.0K | $1.64 | $25K |
| Mar 17, 22 | Leiv LeaChief Financial Officer | BUY | 13.9K | $1.65 | $23K |
| Mar 17, 22 | Miller Richard A MdPresident and CEO | BUY | 5.0K | $1.59 | $8K |
| Mar 16, 22 | Leiv LeaChief Financial Officer | BUY | 35.2K | $1.54 | $54K |
| Mar 15, 22 | Miller Richard A MdPresident and CEO | BUY | 25.0K | $1.47 | $37K |
| Oct 1, 21 | Ecor1 Capital, LlcTenPercentOwner | SELL | 2.00M | $4.96 | $9.9M |
| Sep 30, 21 | Ecor1 Capital, LlcTenPercentOwner | SELL | 3.00M | $5.04 | $15.1M |
| Sep 20, 21 | Orbimed Capital Gp V LlcDirector,TenPercentOwner | SELL | 1.11M | $6.09 | $6.8M |
| Sep 20, 21 | Peter A. ThompsonDirector,TenPercentOwner | SELL | 1.11M | $6.09 | $6.8M |
| Aug 20, 21 | Miller Richard A MdPresident and CEO | BUY | 10.0K | $1.93 | $19K |
Over the past 12 months, insiders at Corvus Pharmaceuticals, Inc. filed 3 open-market purchases worth $334K and 0 sales worth $0 on CRVS, which makes them net buyers over the period. The most recent Form 4 was filed on Jun 11, 26.
The largest recent open-market CRVS insider purchase in our data was $999K by Miller Richard A Md, President and CEO, filed on May 6, 24.
2 different insiders at Corvus Pharmaceuticals, Inc. filed open-market SEC Form 4 transactions on CRVS over the last 12 months.
InsiderTape plots every CRVS insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Corvus Pharmaceuticals, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →